Maven Brands Stock Fundamentals
Maven Brands fundamentals help investors to digest information that contributes to Maven Brands' financial success or failures. It also enables traders to predict the movement of Maven Pink Sheet. The fundamental analysis module provides a way to measure Maven Brands' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Maven Brands pink sheet.
Maven |
Maven Brands Company Return On Equity Analysis
Maven Brands' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Maven Brands Return On Equity | -3.83 |
Most of Maven Brands' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Maven Brands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Maven Brands has a Return On Equity of -3.8282. This is 84.03% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Maven Brands Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Maven Brands's current stock value. Our valuation model uses many indicators to compare Maven Brands value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Maven Brands competition to find correlations between indicators driving Maven Brands's intrinsic value. More Info.Maven Brands is rated fourth in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Maven Brands' earnings, one of the primary drivers of an investment's value.Maven Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Maven Brands' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Maven Brands could also be used in its relative valuation, which is a method of valuing Maven Brands by comparing valuation metrics of similar companies.Maven Brands is currently under evaluation in return on equity category among its peers.
Maven Fundamentals
| Return On Equity | -3.83 | |||
| Return On Asset | -0.16 | |||
| Current Valuation | 4.98 M | |||
| Shares Outstanding | 35.04 M | |||
| Shares Owned By Insiders | 11.62 % | |||
| Price To Earning | (22.40) X | |||
| Price To Book | 19.18 X | |||
| Price To Sales | 56.06 X | |||
| Gross Profit | 1.02 M | |||
| EBITDA | (1.8 M) | |||
| Net Income | (2.46 M) | |||
| Cash And Equivalents | 106.24 K | |||
| Total Debt | 6.1 M | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 0.11 X | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (1.77 M) | |||
| Earnings Per Share | (0.09) X | |||
| Beta | 2.53 | |||
| Market Capitalization | 651.31 K | |||
| Total Asset | 5.07 M | |||
| Net Asset | 5.07 M |
About Maven Brands Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maven Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maven Brands using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maven Brands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Maven Brands Inc. cultivates, processes, and sells medical cannabis. Maven Brands Inc. was founded in 2013 and is based in Vernon, Canada. Maven Brands operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Maven Pink Sheet
Maven Brands financial ratios help investors to determine whether Maven Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maven with respect to the benefits of owning Maven Brands security.